• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial Concerning "The Association Between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based Study".

作者信息

Kiemeney Lambertus A L M

机构信息

Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

Bladder Cancer. 2023 Mar 31;9(1):83-85. doi: 10.3233/BLC-239004. eCollection 2023.

DOI:10.3233/BLC-239004
PMID:38994476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11181817/
Abstract
摘要

相似文献

1
Editorial Concerning "The Association Between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based Study".关于《尿路上皮癌患者诊断时糖尿病药物使用与肿瘤特征之间的关联：一项基于登记处的回顾性研究》的社论
Bladder Cancer. 2023 Mar 31;9(1):83-85. doi: 10.3233/BLC-239004. eCollection 2023.
2
The Association between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based Study.尿路上皮癌患者糖尿病药物使用与诊断时肿瘤特征之间的关联：一项基于回顾性登记的研究。
Bladder Cancer. 2023 Mar 31;9(1):73-82. doi: 10.3233/BLC-220082. eCollection 2023.
3
Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study.低级别乳头状尿路上皮癌的肿瘤行为：一项单中心回顾性研究
Cureus. 2021 Jun 29;13(6):e16012. doi: 10.7759/cureus.16012. eCollection 2021 Jun.
4
The prognostic significance of HER2 expression in urothelial carcinoma.HER2 表达在尿路上皮癌中的预后意义。
Malays J Pathol. 2022 Aug;44(2):245-252.
5
Prognostic impact of non-urothelial carcinoma of the upper urinary tract: Analysis of hospital-based cancer registry data in Japan.上尿路非尿路上皮癌的预后影响：日本基于医院癌症登记数据的分析。
Int J Urol. 2021 Jan;28(1):54-60. doi: 10.1111/iju.14393. Epub 2020 Nov 9.
6
Rare tumours of the bladder: A Saudi registry based descriptive study.膀胱罕见肿瘤：一项基于沙特登记处的描述性研究。
J Taibah Univ Med Sci. 2022 Jan 21;17(4):573-577. doi: 10.1016/j.jtumed.2021.12.002. eCollection 2022 Aug.
7
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南：2017 年更新版。
Eur Urol. 2018 Jan;73(1):111-122. doi: 10.1016/j.eururo.2017.07.036. Epub 2017 Sep 1.
8
Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome.基于尿分析的林奇综合征患者尿路上皮癌筛查评估。
Dis Colon Rectum. 2022 Jan 1;65(1):40-45. doi: 10.1097/DCR.0000000000002062.
9
Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini.p63 和高分子量细胞角蛋白在鉴别伴有前列腺间质浸润的尿路上皮癌与伴有前列腺导管和腺泡浸润的尿路上皮癌中的作用。
Pathology. 2012 Apr;44(3):199-203. doi: 10.1097/PAT.0b013e3283511c73.
10
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.在上尿路尿路上皮癌患者接受肾输尿管切除术和膀胱袖状切除术治疗中，肿瘤位置与多灶性的影响：无围手术期化疗的同质系列。
BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.

本文引用的文献

1
Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.糖尿病和肥胖症作为膀胱癌预后的危险因素：系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Oct 7;12:699732. doi: 10.3389/fendo.2021.699732. eCollection 2021.
2
The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.二甲双胍对泌尿系统癌症患者生存结局的影响：一项系统评价和荟萃分析。
Biomed Res Int. 2021 Oct 8;2021:5311828. doi: 10.1155/2021/5311828. eCollection 2021.
3
More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.最近，设计更完善的研究削弱了降糖药物与癌症风险之间的关联。
Diabet Med. 2020 Feb;37(2):194-202. doi: 10.1111/dme.14179. Epub 2020 Jan 3.
4
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?癌症、肥胖、糖尿病和抗糖尿病药物：迷雾正在消散吗？
Nat Rev Clin Oncol. 2017 Feb;14(2):85-99. doi: 10.1038/nrclinonc.2016.120. Epub 2016 Aug 9.
5
Pioglitazone use and risk of bladder cancer: population based cohort study.吡格列酮的使用与膀胱癌风险：基于人群的队列研究。
BMJ. 2016 Mar 30;352:i1541. doi: 10.1136/bmj.i1541.
6
Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies.肥胖与膀胱癌风险：15项队列研究的剂量反应荟萃分析
PLoS One. 2015 Mar 24;10(3):e0119313. doi: 10.1371/journal.pone.0119313. eCollection 2015.
7
Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies.糖尿病患者膀胱癌风险：36 项观察性研究的更新荟萃分析。
BMC Cancer. 2013 Jun 26;13:310. doi: 10.1186/1471-2407-13-310.